Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: If we only still had the $20,000,000+ they wasted on worthless M&As. eom

Yes, but you could have at least 1/3 of the company's shares retired and removed from the float and dilutive / distributive market forces. That would inturn immediately raise the value of your present shares by at least 1/3, and make owning our fewer remaining shares more desirable; especially in a dividend paying environment.

That's for starters ....

Oh well, just another opportunity lost from fallout resulting from our BOD's leadership failures.

Share
New Message
Please login to post a reply